Qualified Person (QP) Services
Providing around the clock support, enabled by at least two QPs per assignment, delivering full continuity, and reduced risk.
Maximize Compliance and Quality with ProPharma's Expert Support
Our expert team offers enhanced Quality Unit support, MIA and WDA licensing guidance, and GMP compliance, ensuring your products meet EU and UK regulations. Connect with a ProPharma expert today to maintain the highest levels of safety and consistency.
Qualified Person Services for EU and UK Markets
Companies that intend to manufacture or import medicinal products in the EU and UK require a Manufacturing and Import Authorization (MIA) license and a designated named Qualified Person (QP) to oversee the product quality throughout the supply chain. Acting as an extension of your organization, our QP consultants bring a deep understanding of GMP processes. They work with your tesam to ensure compliant manufacturing and/or importation of products in the EU and UK markets. Our global team of certified QPs have broad experience covering multiple types of formulations, complex supply chains, technical transfer projects, aseptic/sterile manufacturing, radiopharmaceuticals, biologics, ATMPs, and supply for clinical trials.
Navigating Regulatory Requirements for Medicinal Products
Every organization in the life sciences industry is required to have a current and compliant quality system to ensure the safety and quality of all products and services. Quality assurance involves upholding the desired level of quality in your products throughout every stage of the process, from production to delivery to the patient.
ProPharma's quality assurance professionals enhance your internal capabilities to ensure the consistency and safety of products. Our team acts as an extension of your Quality Unit, utilizing a hands-on and risk-based approach to quickly improve quality and compliance while implementing practical solutions for your organization.
Enhancing Quality with Qualified Person Services
To procure, sell and distribute medicinal products in the EU and the UK markets you need a Wholesaler Dealer Authorization (WDA) and a Responsible Person (RP) named on the license. In the UK a WDA can also be utilized to import QP-certified medicinal products from the EU. In that case, you would need a Responsible Person (import). The RP is tasked with supervising the quality of the company's wholesale operation and takes on the primary responsibility for ensuring compliance with GDP regulations and maintaining the quality of the distributed products.
Our highly experienced RPs can act as contractors named on your, or a third-party's, WDA for both human and veterinary medicines under EU and UK Guidelines. If you are new to the EU/UK market we can help you in navigating the road from QMS build, through the WDA application process, a successful inspection, and obtaining your very own WDA license.
Specialized QP/RP/RPi Services
ProPharma's global team of certified experts have broad experience covering multiple types of formulations, complex supply chains, technical transfer projects, aseptic/sterile manufacturing, radiopharmaceuticals, biologics, ATMP's, market access and supply for clinical trials.
Our QP/RP/RPi services include
Partnering with your organization to lead or assist in obtaining the manufacturer’s import license and wholesale distributor license
Partnering with your organization to lead or assist in obtaining the manufacturer’s import license and wholesale distributor license
Read LessProviding strategic recommendations in addition to standard QP oversight. We will support your organization to reduce issues, delays, and costs in the manufacturing process
Providing strategic recommendations in addition to standard QP oversight. We will support your organization to reduce issues, delays, and costs in the manufacturing process
Read LessHelping organizations develop a flexible staffing model that caters to specific needs ranging from long-term lead assignments (named on the client's license) to interim support
Helping organizations develop a flexible staffing model that caters to specific needs ranging from long-term lead assignments (named on the client's license) to interim support
Read LessQP Declaration
QP Confirmation
QP Batch Certification
QP Declaration
QP Confirmation
QP Batch Certification
Read LessExperience building Quality Management Systems (QMS) and providing full oversight of the QMS to maintain product quality in the distribution to pharmacies, hospitals, or other wholesalers
Experience building Quality Management Systems (QMS) and providing full oversight of the QMS to maintain product quality in the distribution to pharmacies, hospitals, or other wholesalers
Read LessSupply chain mapping and risk assessment thereof to comply with the Falsified Medicines Directive 2011/62/EU
Supply chain mapping and risk assessment thereof to comply with the Falsified Medicines Directive 2011/62/EU
Read Less
Experience in EU & UK
- Import and Batch Certification services for ATMPs, Biologics, Radiopharmaceuticals, vaccines and small molecules for both IMP and commercial products in EU.
- Import and Batch Certification services for commercial Oral Solid Dosage products. QP Oversight of all types of IMP imported to the UK from the EEA.
Support for Pharmaceutical Products & Services
Our QP/RP/RPi experts can support a variety of products for the pharmaceutical industry, including:
- Tablets
- Capsules, both hard and soft shell
- Liquids, creams, and ointments, both sterile and non-sterile
- Sterilization by filtration, irradiation, and ethylene oxide
- API supplier auditing, both small and large molecule to EU GMP Part II/ ICH Q7
- Excipient supplier auditing to IPEC-PQG guidelines
- Packaging supplies auditing, covering leaflets, labels, cartons, foils & films, primary containers to GMP, and PS9000:2016
- Contract analytical laboratory auditing to GMP and ISO 17025:2017
- Storage and distribution warehouse auditing to GDP
- ATMPs
- Biologics
- Radiopharmaceuticals
- Vaccines
- IMP
- Commercial products
Interim Qualified Person (QP)
Companies that intend to manufacture, import, sell or distribute pharmaceutical products in the EU/UK require a MIA license and a designated Qualified Person (QP) to oversee the product quality, and ultimately certify each batch of medicinal product for being manufactured, tested and released in accordance with EU GMP and the documents submitted to the EU/UK authorities.
In certain instances, volumes or circumstances may not justify hiring a QP. In such situations our QPs act as an extension of your organization, bringing a deep understanding of Good Manufacturing Practice (GMP) processes. They work with your team to ensure compliant manufacturing and distribution of products in the EU/UK market.
Interim Responsible Person (RP/RPi) Services
Wholesaling of Medicinal Products and Active Pharmaceutical Ingredients Under GDP
Our team of extensively skilled QPs and RPs is ready to function as contractors listed on your or a third parties Wholesale Dealers Authorization for both human and veterinary medicines under European Guidelines 2013/C 343/01 human medicines and 2015/C 95/01 APIs for medicinal products for human use.
Complex Needs Require Custom Solutions
Unlock your organization's potential in the life sciences industry with ProPharma's specialized QP/RP/RPi services. Partner with our global team of certified experts to ensure compliance, enhance product quality, and streamline your manufacturing and distribution processes.
How to Successfully Launch Products with QMS and QP Certification
Reaching patients in the EU with needed medicinal products is a complex undertaking that not only requires knowledge of varied regulatory landscapes, companies must also man, the services of a...
Ensure Successful Batch Release, Regulatory Compliance with Experienced Qualified Persons
Streamlining a CMO’s manufacturing process helped ensure GMP compliance for EU batch release and USA inspection readiness. A contract manufacturing organization (CMO) needs to have a reliable quality...
Our QP's provide 360 degree support to ensure successful batch release, including coordination with other parties, and fair pricing for additional but required activities.
Typically, the competition charges high price for everything outside of the standard program.
Our QP's provide 360 degree support to ensure successful batch release, including coordination with other parties, and fair pricing for additional but required activities.
Typically, the competition charges high price for everything outside of the standard program.
News & Insights
February 2, 2026
AI in PV Surveillance: Aligning Innovation with Regulatory Expectations
Explore how AI is transforming pharmacovigilance while ensuring patient safety, data integrity, and regulatory compliance with insights from the 2025 CIOMS report.
January 29, 2026
Preparing for eCTD 4.0: What FDA Submitters Need to Know
eCTD 4.0 is coming. Learn what’s changing, why early planning matters, and how FDA submitters can prepare for a smooth transition.
January 27, 2026
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...
ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.
December 11, 2025
ProPharma Expands Operations with New Office in Hyderabad
ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
February 5, 2026
Setting up a Global PV System
A company needed to rapidly establish a fully compliant global pharmacovigilance (PV) system, including UK/EU QPPV coverage, to meet regulatory requirements by a fixed deadline. With safety data and...
January 30, 2026
High-Volume Global Pharmacovigilance Onboarding
A global biotechnology sponsor faced a sudden surge in pharmacovigilance demand, with monthly ICSR volumes exceeding 30,000 cases across multiple regions. Limited internal capacity, tight onboarding...
March 12, 2026
Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs
Uncover the intricacies of Pharmacovigilance System Master File (PSMF) management and explore proven strategies to ensure inspection readiness, effective MAH oversight, and regulatory compliance...
February 17, 2026
Evolving FDA Expectations: How High-Functioning MLR Teams Manage Risk in 2026
With promotional scrutiny increasing around areas such as social media, influencer campaigns, direct-to-consumer (DTC) messaging, and data-driven claims, the session walks through the characteristics...
News & Insights